IGHE and asthma: The suppressed release of β-hexosaminidase from RBL-2H3 cells, which is typically triggered by IgE–antigen complexes as mast cell activators, highlighted the inhibitory effects of the selected compounds on mast cell degranulation and the release of histamine-containing granules, which is a key inflammatory response associated with asthma [71].